Arrowhead Pharmaceuticals Home I Arrowhead Pharmaceuticals
Changing the way diseases are treated, Arrowhead pharmaceuticals uses innovative, scientific methods to discover, develop, and deliver therapies and solutions.
Our Pipeline | Arrowhead Pharmaceuticals
Check out the development of Arrowhead’s products to treat challenging cardiometabolic, pulmonary, neuromuscular, liver, and more types of diseases.
About Us | Arrowhead Pharmaceuticals
Learn more about Arrowhead Pharmaceutical's foundation as a therapeutic discovery company, innovative use of RNAi, and ambitious pipeline for developing medicines.
Careers | Arrowhead Pharmaceuticals
Join Arrowhead and collaborate with our innovative experts. Let's push the boundaries of science and redefine the treatment of difficult diseases together.
Science & Innovation | Arrowhead Pharmaceuticals
See Arrowhead's scientific and innovative discovery and development platform, producing effective new therapies that are cost effective and may have a lower risk.
Newsroom | Arrowhead Pharmaceuticals
Stay up to date on Arrowhead Pharmaceutical's latest news, stories, and events. Read about recent studies on potential treatments, healthcare conferences, and more!
Arrowhead Pharmaceuticals Receives FDA Breakthrough Therapy …
Arrowhead is committed to bringing new investigational medicines to patients with serious diseases as quickly and efficiently as possible. The company has established an expanded access program (EAP) for some individuals living with FCS.
Financials & Filings - Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Fiscal 2024 Year End Results. Arrowhead Pharmaceuticals Reports 2024 Fiscal Year-End Results. Form 10-K. Proxy Statements. Filing Date View; Jan 26, 2024: 0001628280-24-002375.pdf. 0001628280-24-002375.rtf. 0001628280-24-002375.xls. EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML.
Contact Us | Arrowhead Pharmaceuticals
Please contact us with questions, concerns, or to receive any further information. Thank you for your interest to learn more about Arrowhead Pharmaceuticals.
Arrowhead Pharmaceuticals Reports 2024 Fiscal Year-End Results
Nov 26, 2024 · Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its 2024 fiscal year ended September 30, 2024. The Company is hosting a conference call today, November 26, 2024, at 4:30 p.m. ET to discuss the results.
- Some results have been removed